Simcere Pharmaceutical Group (先声药业) and Sun Yat-Sen University Cancer Center of Guangzhou have established a strategic relationship to develop cancer drugs. In addition, the two companies will build a joint program to train personnel in advanced R&D. The company did not disclose any specifics about the nature of the cancer drug investigation, though the research at Sun Yat-Sen University Cancer Center focuses on innovative drugs. More details...

Stock Symbol: (NYSE: SCR)